Filed: 5/15/2026ACC: 0001744967-26-000005
📋 What this filing means
SAMSARA BIOCAPITAL, LLC filed this quarterly 13F‑HR report disclosing 22 equity positions with a total reported market value of $1.03B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
22
Positions
$1.03B
Total AUM (reported)
75.05M
Total Shares
Allocation by class
COM$860.28M83.6%
COM SHS$81.15M7.9%
ADS$28.83M2.8%
COM NEW$21.18M2.1%
SPONSORED ADS$12.59M1.2%
CL A NEW$11.84M1.2%
COMMON STOCK$6.99M0.7%
Portfolio Concentration
Top 3$637.92M62.0%
4–10$308.59M30.0%
11–25$82.59M8.0%
Top 3 weight
62.0%
Top 10 weight
92.0%
Voting Authority Distribution
Total shares with voting rights: 75.05M
Sole
Full voting authority
75.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole22
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings22
Rows:
SCHOLAR ROCK HLDG CORP
SOLEShares6.90M
TypeSH
Market value$339.09M
32.95%
Sole
6.90M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares5.87M
TypeSH
Market value$159.05M
15.45%
Sole
5.87M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares6.35M
TypeSH
Market value$139.79M
13.58%
Sole
6.35M
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares3.15M
TypeSH
Market value$75.67M
7.35%
Sole
3.15M
Shared
0.00
None
0.00
KALARIS THERAPEUTICS INC
SOLEShares12.95M
TypeSH
Market value$74.71M
7.26%
Sole
12.95M
Shared
0.00
None
0.00
SPYGLASS PHARMA INC
SOLEShares2.11M
TypeSH
Market value$54.67M
5.31%
Sole
2.11M
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares1.72M
TypeSH
Market value$34.62M
3.36%
Sole
1.72M
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares5.19M
TypeSH
Market value$28.83M
2.80%
Sole
5.19M
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares1.06M
TypeSH
Market value$26.48M
2.57%
Sole
1.06M
Shared
0.00
None
0.00
JADE BIOSCIENCES INC
SOLEShares968.80K
TypeSH
Market value$13.61M
1.32%
Sole
968.80K
Shared
0.00
None
0.00
VTV THERAPEUTICS INC
SOLEShares298.50K
TypeSH
Market value$11.84M
1.15%
Sole
298.50K
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
SOLEShares2.50M
TypeSH
Market value$10.38M
1.01%
Sole
2.50M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares1.83M
TypeSH
Market value$7.57M
0.74%
Sole
1.83M
Shared
0.00
None
0.00
NKARTA INC
SOLEShares3.51M
TypeSH
Market value$7.40M
0.72%
Sole
3.51M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares60.87K
TypeSH
Market value$6.99M
0.68%
Sole
60.87K
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares736.05K
TypeSH
Market value$6.62M
0.64%
Sole
736.05K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares56.58K
TypeSH
Market value$6.30M
0.61%
Sole
56.58K
Shared
0.00
None
0.00
AGOMAB THERAPEUTICS NV
SOLEShares600K
TypeSH
Market value$6.29M
0.61%
Sole
600K
Shared
0.00
None
0.00
RANI THERAPEUTICS HLDGS INC
SOLEShares8.50M
TypeSH
Market value$6.25M
0.61%
Sole
8.50M
Shared
0.00
None
0.00
COHERUS ONCOLOGY INC
SOLEShares3.43M
TypeSH
Market value$5.79M
0.56%
Sole
3.43M
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC NE
SOLEShares38.43K
TypeSH
Market value$4.79M
0.47%
Sole
38.43K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares7.22M
TypeSH
Market value$2.37M
0.23%
Sole
7.22M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SCHOLAR ROCK HLDG CORPSOLE | COM | 6.90M | SH | $339.09M 32.95% | 6.90M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 5.87M | SH | $159.05M 15.45% | 5.87M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 6.35M | SH | $139.79M 13.58% | 6.35M | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 3.15M | SH | $75.67M 7.35% | 3.15M | 0.00 | 0.00 |
KALARIS THERAPEUTICS INCSOLE | COM | 12.95M | SH | $74.71M 7.26% | 12.95M | 0.00 | 0.00 |
SPYGLASS PHARMA INCSOLE | COM SHS | 2.11M | SH | $54.67M 5.31% | 2.11M | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 1.72M | SH | $34.62M 3.36% | 1.72M | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 5.19M | SH | $28.83M 2.80% | 5.19M | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM SHS | 1.06M | SH | $26.48M 2.57% | 1.06M | 0.00 | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 968.80K | SH | $13.61M 1.32% | 968.80K | 0.00 | 0.00 |
VTV THERAPEUTICS INCSOLE | CL A NEW | 298.50K | SH | $11.84M 1.15% | 298.50K | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCSOLE | COM | 2.50M | SH | $10.38M 1.01% | 2.50M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 1.83M | SH | $7.57M 0.74% | 1.83M | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 3.51M | SH | $7.40M 0.72% | 3.51M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 60.87K | SH | $6.99M 0.68% | 60.87K | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 736.05K | SH | $6.62M 0.64% | 736.05K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 56.58K | SH | $6.30M 0.61% | 56.58K | 0.00 | 0.00 |
AGOMAB THERAPEUTICS NVSOLE | SPONSORED ADS | 600K | SH | $6.29M 0.61% | 600K | 0.00 | 0.00 |
RANI THERAPEUTICS HLDGS INCSOLE | COM CL A | 8.50M | SH | $6.25M 0.61% | 8.50M | 0.00 | 0.00 |
COHERUS ONCOLOGY INCSOLE | COM | 3.43M | SH | $5.79M 0.56% | 3.43M | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INC NESOLE | COM | 38.43K | SH | $4.79M 0.47% | 38.43K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 7.22M | SH | $2.37M 0.23% | 7.22M | 0.00 | 0.00 |